SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-12-002111
Filing Date
2012-03-08
Accepted
2012-03-08 16:02:38
Documents
4
Period of Report
2012-03-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pdlbio_8k-030812.htm 8-K 30932
2 PRESS RELEASE ex99-1.htm EX-99.1 27616
3 INFORMATION SHEET ex99-2.htm EX-99.2 390222
4 IMAGE pdllogo.jpg GRAPHIC 2519
  Complete submission text file 0001437749-12-002111.txt   453572
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 12677323
SIC: 2836 Biological Products, (No Diagnostic Substances)